Alessandra d'Azzo
Affiliations: | Neuroscience | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Neuroscience Biology, GeneticsGoogle:
"Alessandra d'Azzo"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luu AR, Wong H, Agrawal V, et al. (2020) Lysosome-targeted β-galactosidase negatively regulates neuraminidase 1 (NEU1) and promotes NEU1 deficiency in GM1 gangliosidosis. The Journal of Biological Chemistry |
| Han MJ, Annunziata I, Weesner J, et al. (2020) Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations. Stem Cell Research. 46: 101836 |
| Lawrence R, Van Vleet JL, Mangini L, et al. (2019) Characterization of glycan substrates accumulating in GM1 Gangliosidosis. Molecular Genetics and Metabolism Reports. 21: 100524 |
| Chen JC, Luu AR, Wise N, et al. (2019) Intracerebroventricular enzyme replacement therapy with Beta-Galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice. The Journal of Biological Chemistry |
| Romancino DP, Buffa V, Caruso S, et al. (2018) Palmitoylation is a post-translational modification of Alix regulating the membrane organization of exosome-like small extracellular vesicles. Biochimica Et Biophysica Acta. General Subjects. 1862: 2879-2887 |
| Annunziata I, d'Azzo A. (2017) Galactosialidosis: historic aspects and overview of investigated and emerging treatment options. Expert Opinion On Orphan Drugs. 5: 131-141 |
| Ayala J, Acosta W, Condori J, et al. (2016) Uptake, lysosomal activation, and disease correction in GM1 Gangliosidosis cells by plant-made β-galactosidase: Lectin fusions Molecular Genetics and Metabolism. 117 |
| d'Azzo A, Machado E, Annunziata I. (2015) Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis. Expert Opinion On Orphan Drugs. 3: 491-504 |
| Bonardi D, Ravasio V, Borsani G, et al. (2014) In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization. Plos One. 9: e104229 |
| Annunziata I, Patterson A, Helton D, et al. (2013) Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis Nature Communications. 4 |